T urban et al. (1) recently reported a surprise finding that moderately elevated 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) expression in the pancreatic b-cells promoted a compensation against high-fat (HF) diet-induced b-cell failure because glucocorticoids are well established to impair insulin secretion and cause b-cell death and insulin resistance in key insulin targets. Rather than accepting the U-shaped dose response, nongenomic (glucocorticoid receptor-independent) mechanism, or even mineralocorticoid receptor-mediated effect, a simpler approach is to question the model. While we have no reason to doubt the data integrity, the evidence used to establish HF dietinduced b-cell failure was far from convincing. Although an established procedure of using a 58% fat diet to feed mice for 12 weeks was used, wild-type mice did not become obese by gaining any weight, there was no elevation in fasting blood glucose and serum insulin levels (Table  1) , and no significant decrease in glucose-stimulated insulin secretion caused by HF diet and measured by area under the curve (Fig. 2C, first two columns in ref. 1) , leading one to question the authors' statement that "HFfed KsJ mice . showed markedly attenuated GSIS [glucosestimulated insulin secretion] indicative of b-cell failure and . (Fig. 2B and C)" (1) . The HF feeding experiment has clearly failed to cause obesity and insulin resistance versus our previously published findings (2); there was no obvious sign of b-cell failure. How could one compensate a nonfailure?
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